NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004. (Treatment Improvement Protocol (TIP) Series, No. 40.)

Cover of Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction.

Show details


  • Tony Aguilar, L.M.F.T.
  • Legislative Consultant
  • California Department of Social Services
  • Sacramento, California
  • Daniel Alford, M.D., M.P.H.
  • Association for Medical Education and Research in Substance Abuse (AMERSA)
  • Assistant Professor of Medicine
  • Boston University School of Medicine
  • Clinical Addiction Research and Education Unit
  • Boston, Massachusetts
  • Catherine T. Baca, M.D.
  • Clinical Supervisor
  • Center on Alcoholism, Substance Abuse, and Addictions
  • Albuquerque, New Mexico
  • Thomas J. Croce, Jr., R.Ph. (replacing Jann B. Skelton)
  • Senior Manager
  • Strategic Alliances
  • American Pharmaceutical Association
  • Philadelphia, Pennsylvania
  • George De Leon, Ph.D.
  • Director
  • Center for Therapeutic Community Research of The National Development and Research Institutes
  • New York, New York
  • Elizabeth F. Howell, M.D.
  • Senior Medical Editor
  • Atlanta, Georgia
  • Martin Iguchi, Ph.D.
  • Senior Behavioral Scientist
  • Director
  • Drug Policy Research Center
  • Rand Corporation
  • Santa Monica, California
  • Herbert D. Kleber, M.D.
  • Professor of Psychiatry
  • Director
  • The Division on Substance Abuse
  • Columbia University
  • New York, New York
  • Ervin Lewis, M.D.
  • Area Chief Medical Officer
  • Albuquerque Area Indian Health Service
  • Albuquerque, New Mexico
  • James J. Manlandro, D.O.
  • Medical Director
  • Family Addiction Treatment Services
  • Rio Grande, New Jersey
  • Andrew J. Saxon, M.D.
  • Professor
  • Department of Psychiatry and Behavioral Sciences
  • University of Washington
  • Center of Excellence in Substance Abuse Treatment and Education
  • VA Puget Sound Health Care System
  • Seattle, Washington
  • Charles R. Schuster, Ph.D.
  • Professor
  • Department of Psychiatry and Behavioral Neuroscience
  • Wayne State University School of Medicine
  • Detroit, Michigan
  • Audrey Sellers, M.D.
  • Medical Director
  • Bay Area Addiction Research and Treatment, Inc.
  • San Francisco, California
  • Jann B. Skelton, R.Ph., M.B.A.
  • Vice President
  • U.S. Wellness, Inc.
  • Gaithersburg, Maryland
  • David E. Smith, M.D.
  • President and Founder
  • Haight Ashbury Free Clinic
  • San Francisco, California
  • Eric C. Strain, M.D.
  • Professor
  • Johns Hopkins University School of Medicine
  • Baltimore, Maryland
  • Joycelyn Woods, M.A.
  • President
  • National Alliance of Methadone Advocates
  • New York, New York
PubReader format: click here to try


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.1M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...